- Home
- ACIU vs VPG Comparison
ACIU vs VPG Comparison
Compare ACIU & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- VPG
- Stock Information
- Founded
- ACIU 2003
- VPG 2009
- Country
- ACIU Switzerland
- VPG United States
- Employees
- ACIU N/A
- VPG N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- VPG Electrical Products
- Sector
- ACIU Health Care
- VPG Technology
- Exchange
- ACIU Nasdaq
- VPG Nasdaq
- Market Cap
- ACIU 332.4M
- VPG 306.5M
- IPO Year
- ACIU 2016
- VPG N/A
- Fundamental
- Price
- ACIU $2.68
- VPG $23.06
- Analyst Decision
- ACIU Strong Buy
- VPG Hold
- Analyst Count
- ACIU 2
- VPG 1
- Target Price
- ACIU $12.00
- VPG $31.00
- AVG Volume (30 Days)
- ACIU 132.5K
- VPG 123.6K
- Earning Date
- ACIU 11-05-2024
- VPG 02-12-2025
- Dividend Yield
- ACIU N/A
- VPG N/A
- EPS Growth
- ACIU N/A
- VPG N/A
- EPS
- ACIU N/A
- VPG 0.99
- Revenue
- ACIU $48,505,404.00
- VPG $323,397,000.00
- Revenue This Year
- ACIU $85.33
- VPG N/A
- Revenue Next Year
- ACIU $80.69
- VPG $1.31
- P/E Ratio
- ACIU N/A
- VPG $23.29
- Revenue Growth
- ACIU 4097200.00
- VPG N/A
- 52 Week Low
- ACIU $2.25
- VPG $20.83
- 52 Week High
- ACIU $5.14
- VPG $35.98
- Technical
- Relative Strength Index (RSI)
- ACIU 27.49
- VPG 46.92
- Support Level
- ACIU $2.62
- VPG $22.74
- Resistance Level
- ACIU $3.02
- VPG $24.48
- Average True Range (ATR)
- ACIU 0.15
- VPG 0.87
- MACD
- ACIU -0.05
- VPG -0.11
- Stochastic Oscillator
- ACIU 9.52
- VPG 11.85
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates majority of its revenue from United States.